Lng trm (crnt) use injectable non-insulin antidiabetic drugs

This code indicates a patient is currently receiving ongoing treatment with non-insulin antidiabetic medications administered via injection. These drugs help manage blood glucose levels in individuals with diabetes but are distinct from insulin itself. Examples include GLP-1 receptor agonists or amylin analogs.

Assign this code when a patient is actively prescribed and using injectable antidiabetic medications other than insulin for long-term management of their diabetes. This is typically used as a secondary diagnosis to provide additional information about the patient's current medication regimen.

• Always sequence this code after the primary diagnosis for the patient's diabetes (e.g., E11.9 for Type 2 diabetes mellitus).
• Do not use this code if the patient is taking oral antidiabetic medications or insulin; refer to the Excludes2 notes for appropriate alternatives.
• Ensure documentation clearly specifies an injectable non-insulin antidiabetic drug is being used for ongoing treatment.